Filing Details
- Accession Number:
- 0001179110-21-011004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-15 18:26:51
- Reporting Period:
- 2021-12-14
- Accepted Time:
- 2021-12-15 18:26:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428336 | Healthequity Inc. | HQY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1163402 | T Adrian Dillon | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-14 | 12,375 | $40.47 | 44,083 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $46.40 | 2027-02-01 | 4,837 | 4,837 | Direct | |
Common Stock | Stock Option (right to buy) | $50.41 | 2028-02-01 | 4,339 | 4,339 | Direct | |
Common Stock | Stock Option (right to buy) | $63.64 | 2029-02-01 | 3,626 | 3,626 | Direct | |
Common Stock | Stock Option (right to buy) | $32.50 | 2026-09-01 | 7,632 | 7,632 | Direct | |
Common Stock | Stock Option (right to buy) | $66.06 | 2030-02-01 | 4,012 | 4,012 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-02-01 | 4,837 | 4,837 | Direct |
2028-02-01 | 4,339 | 4,339 | Direct |
2029-02-01 | 3,626 | 3,626 | Direct |
2026-09-01 | 7,632 | 7,632 | Direct |
2030-02-01 | 4,012 | 4,012 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.295 to $40.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4.
- The option is immediately exercisable.